Abbott (NYSE:ABT) and Cardiovascular Systems, Inc. (CSI), today announced a definitive agreement for Abbott to acquire CSI, a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease. Under terms of the agreement, CSI stockholders will receive $20 per common share at a total expected equity value of approximately $890 million.
Snowflake Is Not For Faint-Hearted, Long-Term Opportunity To Good To Overlook: Analyst
Piper Sandler analyst Brent Bracelin reiterates Snowflake Inc (NYSE: SNOW) with an Overweight
